RETINEYE Trademark

Trademark Overview

On Wednesday, May 5, 2021, a trademark application was filed for RETINEYE with the United States Patent and Trademark Office. The USPTO has given the RETINEYE trademark a serial number of 90692491. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, April 12, 2024. The RETINEYE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
retineye

General Information

Serial Number90692491
Word MarkRETINEYE
Filing DateWednesday, May 5, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, April 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code042
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressLexington, US 02420
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressLexington, US 02420

Trademark Events

Event DateEvent Description
Saturday, May 8, 2021NEW APPLICATION ENTERED
Sunday, May 9, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, August 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 6, 2021ASSIGNED TO LIE
Tuesday, July 6, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, January 6, 2022ASSIGNED TO EXAMINER
Wednesday, January 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 12, 2022SOU EXTENSION 1 FILED
Wednesday, October 12, 2022SOU EXTENSION 1 GRANTED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 12, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023SOU EXTENSION 2 FILED
Wednesday, April 12, 2023SOU EXTENSION 2 GRANTED
Thursday, October 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 12, 2023SOU EXTENSION 3 FILED
Thursday, October 12, 2023SOU EXTENSION 3 GRANTED
Saturday, October 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 12, 2024SOU EXTENSION 4 GRANTED
Friday, April 12, 2024SOU EXTENSION 4 FILED
Friday, April 12, 2024SOU TEAS EXTENSION RECEIVED
Saturday, April 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

retineye fields biotechnology pharmaceutical development research